Cambrex completes highly potent API manufacturing facility in Charles City
EAST RUTHERFORD, NJ – Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it had completed